COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
申请人:Alper Phillip B.
公开号:US20100022515A1
公开(公告)日:2010-01-28
The invention provides compounds, pharmaceutical compositions comprising compound of following formula (I), and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119 (G protein-coupled receptor 119) such as obesity, diabetes and hyperlipidemia.